Number of the records: 1  

Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium, BB-12 and Lactobacillus rhamnosus, LGG in colorectal cancer patients: The Probio SK 006-Slovak cooperative oncology group trial

  1. TitleRandomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium, BB-12 and Lactobacillus rhamnosus, LGG in colorectal cancer patients: The Probio SK 006-Slovak cooperative oncology group trial : e24109
    Author Mego Michal
    Co-authors Daniš Radoslav

    Chovanec J.

    Jurišová Silvia

    Bystrický Branislav

    Pörsök Štefan

    Konkolovský Peter

    Václav Vladimír

    Wagnerová Mária

    Streško Marián

    Brezinová Bibiana

    Recková Mária

    Suteková Dagmar

    Pazderová Natália

    Novisedlaková Mária

    Zomborská Eva

    Čierniková Soňa 1978- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV

    Svetlovská Daniela

    Drgoňa Ľuboš

    Source document Journal of Clinical Oncology. Vol. 41, Issue 16 (2023), Suppl. S
    Languageeng - English
    CountryUS - United States of America
    NoteMeeting Abstract
    Document kindrozpis článkov z periodík (rbx)
    CategoryAEMA - Abstracts of scientific papers published in foreign impacted journals registered in Web of Science Core Collection or Scopus
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentabstrakt z podujatia
    Year2023
    article

    article

    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    A
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    2023202245.4Q110.163Q1
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.